|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold | |||||
| Lower of cost or market inventory valuation adjustment | |||||
| Gross (loss) profit | |||||
| Research and development | |||||
| Selling and administrative expenses | |||||
| Restructuring Charges | |||||
| Goodwill impairment charges | |||||
| Operating loss | |||||
| Other (income) expense, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Loss before income taxes | |||||
| Income tax expense (benefit) | |||||
| Net loss | |||||
| Foreign currency translation adjustments, net of tax of $0, $29 and $(8), respectively | |||||
| Commodities, interest rate and foreign currency derivatives, net of tax of $28, $2,111 and $4,424, respectively | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Comprehensive loss | |||||
| Basic loss per common share: | |||||
| Net (loss) income per share (in dollars per share) | |||||
| Weighted average shares outstanding (in shares) | |||||
| Diluted loss per common share: | |||||
| Net (loss) income per share (in dollars per share) | |||||
| Weighted average common shares outstanding (in shares) | |||||
Loading...